The Research Ethics Committee (REC) of Universiti Teknologi MARA (UiTM) was approved by the Vice-Chancellor and established in 2004. The Committee is on Tier 2 (Executive), under the governance of UiTM Research and Innovation, where it reports to the University Research Committee (JKIPU) and to the UiTM Senate.
The objectives of REC are to safeguard the rights, safety and well-being of human research participants, provide timely, comprehensive and independent review of the ethics of proposed studies and ensure that the research complies with existing laws and regulations. The responsibility of the REC includes, but is not limited to the approval/disapproval, amendment or termination of studies which do not conform to the standard guidelines.
All research proposals involving human subjects in UiTM must be approved by the UiTM REC prior to the start of research. When the research involves using the facilities of the Ministry of Health (MOH), researchers should obtain approval from the Medical and Research Ethics Committee (MREC) of the MOH.
The Research Ethics Committee of Universiti Teknologi MARA is registered with the Drug Control Authority, National Pharmaceutical Regulatory Agency until 18 August 2022.
Role of the Research Ethics Committee (REC)
The Research Ethics Committee was established to review the ethics of any research involving human participants conducted in UiTM premises and/or by UiTM researchers. REC should uphold proper ethical standards in scientific research to protect the dignity, rights and welfare of research participants as well as the researchers.
The roles of the REC are to:
a) review applications for ethics approval for research involving human;
b) decide the categories of risk into:
minimal risk - the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.
more than minimal risk - research activities that present greater than minimal risk to human subjects.
[Note: The Research Risk Classification Form (REC 3) completed by applicants will be used to assist risk categorization.]
c) approve or disapprove of the proposed research;
d) impose restrictions and conditions on research, if necessary;
e) review submitted progress reports;
f) suspend or revoke approval of research, if necessary.